Lagura, Wilhelmina B.
HRN: 27-82-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2025
LEVOFLOXACIN 500MG (TAB)
09/30/2025
10/07/2025
ORAL
500mg
Every Other Day
CAP-MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes